Document is current
Any future updates will be listed below
-
Authors
Cheng, Xi
Zhang, Junrong
Wang, Weina
Xia, Dongqin
Liu, Lehan
Xie, Yuanyuan
Du, Rong
Ni, Juanjuan
Zhang, Mu
Ji, Jingjing
Zhang, Hao
Sun, Huihua
Sun, Baolan
Zhang, Yuquan
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82401988)
- License Information
-
More Information
Article History
Received: 2 April 2025
Accepted: 29 October 2025
First Online: 8 December 2025
Declarations
:
: All experimental designs and protocols involving animals were approved by the Laboratory Animal Center of Nantong University (Title of the approved project: Protetive effects of umbilical cord mesenchymal stem cells on obstetric deep venous thrombosis via reducing the ferroptosis of endothelial cells. Approval Form ID: S20221231-003. Date of IACUC approved: 2022/12/31) and complied with the recommendations of the academy’s animal research guidelines.
: Not applicable.
: The authors declare that they have no competing of interest.
: The original source (Cyagen Technology) has confirmed that there was initial ethical approval for collection of human cells, and that the donors had signed informed consent. Information from the company’s website: . The original source has confirmed that there was initial ethical approval for collection of human cells, and that the donors had signed informed consent.
